About this Event
AIHIRA 2027 — Event Overview
4th International Conference on AI in Healthcare, Industry & Regulatory Affairs (AIHIRA 2027)
May 25–27, 2027 | Toronto, Canada
Theme: “Innovating AI, Transforming Healthcare, Shaping Industry”
AIHIRA 2027 is an international hybrid conference bringing together healthcare leaders, AI innovators, researchers, clinicians, pharmaceutical and medical-device professionals, regulatory experts, entrepreneurs, policymakers, investors, and technology specialists to explore the evolving role of artificial intelligence across healthcare, industry, and regulatory affairs.
The conference focuses on how AI can move from research and experimentation toward clinically useful, commercially scalable, safe, high-quality, and regulatory-ready solutions.
What Can Attendees Expect?
Participants can expect a three-day program featuring:
- Keynote presentations from experts across AI, healthcare, technology, business, and regulatory affairs
- Scientific and technical sessions covering emerging AI technologies and applications
- AI in Healthcare — AI/ML applications, clinical innovation, digital health, medical research, and healthcare transformation
- AI Regulatory Affairs & Compliance — FDA AI/ML guidance, Health Canada regulations, EU AI Act & healthcare, regulatory strategy, and compliance
- AI Medical Devices — medical-device classification, Software as a Medical Device (SaMD), AI Quality Management Systems, ISO 13485, ISO 14971, CAPA, and post-market surveillance
- AI Complaint Handling & Vigilance — managing complaints, safety issues, model performance, software updates, and post-market concerns
- Panel discussions and interactive sessions focused on real-world challenges and emerging opportunities
- Workshops and industry sessions designed to encourage practical knowledge exchange
- Poster presentations and exhibitions
- Startup and business sessions connecting innovation with commercialization and investment
- Networking opportunities with researchers, industry professionals, entrepreneurs, regulators, and potential collaborators
- Virtual participation for speakers and delegates who cannot attend in person
Key scientific areas include AI Regulatory Compliance, ISO 13485 & AI, ISO 14971 & AI Risk Management, FDA AI/ML Guidance, Health Canada AI Regulations, EU AI Act & Healthcare, Medical Device Classification, CAPA for AI Medical Devices, AI Quality Management Systems, AI Complaint Handling & Vigilance, and Post-Market Surveillance for AI Medical Devices.
Who Should Attend?
AIHIRA 2027 is designed for:
AI & Technology Professionals • Healthcare Professionals • Clinicians • Researchers • Academicians • Medical-Device Professionals • Pharmaceutical Professionals • Regulatory Affairs Specialists • Quality & Compliance Professionals • Entrepreneurs & Startups • Investors • Policymakers • Students & Young Researchers
Conference Format
AIHIRA 2027 will be conducted as a hybrid event, offering both in-person participation in Toronto and virtual participation. The program includes opening and keynote sessions, technical presentations, panel discussions, workshops, exhibitions, networking activities, poster presentations, and a virtual presentation day.
Venue: Four Points by Sheraton Toronto Mississauga, 6090 Dixie Road, Mississauga, Ontario, Canada.
Join AIHIRA 2027
Whether you are looking to present your research, discover emerging AI technologies, explore regulatory developments, build professional connections, showcase your organization, or exchange ideas with international experts, AIHIRA 2027 provides a platform for cross-sector collaboration.
Event venue & nearby stays
Four Points by Sheraton Toronto Hotel, Mississauga, 6090 Dixie Road, Mississauga, Canada